SpectralTAD
SpectralTAD identifies hierarchical topologically associated domains (TADs) from Hi-C contact matrices to characterize multi-level chromatin organization.
Key Features:
- Hierarchical detection: Detects primary TADs and nested sub-TADs to represent multi-level chromatin organization.
- Sliding window spectral clustering: Implements a sliding window-based, modified spectral clustering framework that uses gaps between consecutive eigenvectors to delineate TAD boundaries.
- Automatic parameter selection: Selects parameters algorithmically without requiring manual tuning.
- Robustness to data variability: Maintains performance across variations in sequencing depth, resolution, and Hi-C data sparsity.
- Output format: Produces BED files containing coordinates of detected TADs for downstream genomic analyses.
- Performance validation: Has been tested against four state-of-the-art TAD callers and identifies domains enriched with classical boundary marks and conserved across biological contexts.
Scientific Applications:
- 3D genome architecture analysis: Characterizes hierarchical TAD structures to inform studies of chromatin organization.
- Gene regulation studies: Enables investigation of how TADs influence gene expression and cellular function.
- Comparative genomics: Facilitates detection of conserved TAD boundaries across cell lines and tissues for comparative analyses.
Methodology:
SpectralTAD applies a sliding window spectral clustering approach to Hi-C contact matrices and identifies domain boundaries by detecting gaps between consecutive eigenvectors, yielding hierarchical TAD calls.
Topics
Details
- License:
- MIT
- Programming Languages:
- R
- Added:
- 1/18/2021
- Last Updated:
- 2/21/2021
Operations
Publications
Cresswell KG, Stansfield JC, Dozmorov MG. SpectralTAD: an R package for defining a hierarchy of topologically associated domains using spectral clustering. BMC Bioinformatics. 2020;21(1). doi:10.1186/s12859-020-03652-w. PMID:32689928. PMCID:PMC7372752.
PMID: 32689928
PMCID: PMC7372752
Funding: - Pharmaceutical Research and Manufacturers of America Foundation: NA